List of Excipients in API nitrofurantoin (monohydrate/macrocrystals)
✉ Email this page to a colleague
Excipients in ANDA-approved (generic) drugs containing nitrofurantoin (monohydrate/macrocrystals)
Detailed excipient profiles for nitrofurantoin (monohydrate/macrocrystals)
Excipient focus: AMMONIA
nitrofurantoin (monohydrate/macrocrystals) drug variants containing AMMONIA
| Company | Ingredient | NDC |
|---|---|---|
| Aurobindo Pharma Limited | nitrofurantoin (monohydrate/macrocrystals) | 65862-929 |
| >Company | >Ingredient | >NDC |
nitrofurantoin (monohydrate/macrocrystals) drug variants not containing AMMONIA
Excipient focus: CARBOMER 934
nitrofurantoin (monohydrate/macrocrystals) drug variants containing CARBOMER 934
| Company | Ingredient | NDC |
|---|---|---|
| Rebel Distributors Corp | nitrofurantoin (monohydrate/macrocrystals) | 21695-300 |
| RedPharm Drug Inc | nitrofurantoin (monohydrate/macrocrystals) | 67296-0528 |
| >Company | >Ingredient | >NDC |
nitrofurantoin (monohydrate/macrocrystals) drug variants not containing CARBOMER 934
Excipient focus: CARBOMER HOMOPOLYMER TYPE A
nitrofurantoin (monohydrate/macrocrystals) drug variants containing CARBOMER HOMOPOLYMER TYPE A
| Company | Ingredient | NDC |
|---|---|---|
| Aurobindo Pharma Limited | nitrofurantoin (monohydrate/macrocrystals) | 65862-929 |
| >Company | >Ingredient | >NDC |
nitrofurantoin (monohydrate/macrocrystals) drug variants not containing CARBOMER HOMOPOLYMER TYPE A
Excipient focus: CARBOMER HOMOPOLYMER TYPE B
nitrofurantoin (monohydrate/macrocrystals) drug variants containing CARBOMER HOMOPOLYMER TYPE B
nitrofurantoin (monohydrate/macrocrystals) drug variants not containing CARBOMER HOMOPOLYMER TYPE B
| Company | Ingredient | NDC |
|---|---|---|
| Rebel Distributors Corp | nitrofurantoin (monohydrate/macrocrystals) | 21695-300 |
| RedPharm Drug Inc | nitrofurantoin (monohydrate/macrocrystals) | 67296-0528 |
| >Company | >Ingredient | >NDC |
Excipient focus: D&C YELLOW NO. 10
nitrofurantoin (monohydrate/macrocrystals) drug variants containing D&C YELLOW NO. 10
nitrofurantoin (monohydrate/macrocrystals) drug variants not containing D&C YELLOW NO. 10
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C BLUE NO. 1
nitrofurantoin (monohydrate/macrocrystals) drug variants containing FD&C BLUE NO. 1
nitrofurantoin (monohydrate/macrocrystals) drug variants not containing FD&C BLUE NO. 1
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C RED NO. 3
nitrofurantoin (monohydrate/macrocrystals) drug variants containing FD&C RED NO. 3
nitrofurantoin (monohydrate/macrocrystals) drug variants not containing FD&C RED NO. 3
Excipient focus: FD&C RED NO. 40
nitrofurantoin (monohydrate/macrocrystals) drug variants containing FD&C RED NO. 40
nitrofurantoin (monohydrate/macrocrystals) drug variants not containing FD&C RED NO. 40
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FERROSOFERRIC OXIDE
nitrofurantoin (monohydrate/macrocrystals) drug variants containing FERROSOFERRIC OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Aurobindo Pharma Limited | nitrofurantoin (monohydrate/macrocrystals) | 65862-929 |
| >Company | >Ingredient | >NDC |
nitrofurantoin (monohydrate/macrocrystals) drug variants not containing FERROSOFERRIC OXIDE
Excipient focus: GELATIN
nitrofurantoin (monohydrate/macrocrystals) drug variants containing GELATIN
nitrofurantoin (monohydrate/macrocrystals) drug variants not containing GELATIN
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: ISOPROPYL ALCOHOL
nitrofurantoin (monohydrate/macrocrystals) drug variants containing ISOPROPYL ALCOHOL
nitrofurantoin (monohydrate/macrocrystals) drug variants not containing ISOPROPYL ALCOHOL
Excipient focus: LACTOSE MONOHYDRATE
nitrofurantoin (monohydrate/macrocrystals) drug variants containing LACTOSE MONOHYDRATE
nitrofurantoin (monohydrate/macrocrystals) drug variants not containing LACTOSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
nitrofurantoin (monohydrate/macrocrystals) drug variants containing MAGNESIUM STEARATE
nitrofurantoin (monohydrate/macrocrystals) drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MANNITOL
nitrofurantoin (monohydrate/macrocrystals) drug variants containing MANNITOL
nitrofurantoin (monohydrate/macrocrystals) drug variants not containing MANNITOL
Excipient focus: POTASSIUM HYDROXIDE
nitrofurantoin (monohydrate/macrocrystals) drug variants containing POTASSIUM HYDROXIDE
nitrofurantoin (monohydrate/macrocrystals) drug variants not containing POTASSIUM HYDROXIDE
Excipient focus: POVIDONE
nitrofurantoin (monohydrate/macrocrystals) drug variants containing POVIDONE
nitrofurantoin (monohydrate/macrocrystals) drug variants not containing POVIDONE
Excipient focus: POVIDONE K30
nitrofurantoin (monohydrate/macrocrystals) drug variants containing POVIDONE K30
nitrofurantoin (monohydrate/macrocrystals) drug variants not containing POVIDONE K30
Excipient focus: POVIDONE K90
nitrofurantoin (monohydrate/macrocrystals) drug variants containing POVIDONE K90
nitrofurantoin (monohydrate/macrocrystals) drug variants not containing POVIDONE K90
Excipient focus: PROPYLENE GLYCOL
nitrofurantoin (monohydrate/macrocrystals) drug variants containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Aurobindo Pharma Limited | nitrofurantoin (monohydrate/macrocrystals) | 65862-929 |
| >Company | >Ingredient | >NDC |
nitrofurantoin (monohydrate/macrocrystals) drug variants not containing PROPYLENE GLYCOL
Excipient focus: SHELLAC
nitrofurantoin (monohydrate/macrocrystals) drug variants containing SHELLAC
nitrofurantoin (monohydrate/macrocrystals) drug variants not containing SHELLAC
Excipient focus: SILICON DIOXIDE
nitrofurantoin (monohydrate/macrocrystals) drug variants containing SILICON DIOXIDE
nitrofurantoin (monohydrate/macrocrystals) drug variants not containing SILICON DIOXIDE
Excipient focus: SODIUM LAURYL SULFATE
nitrofurantoin (monohydrate/macrocrystals) drug variants containing SODIUM LAURYL SULFATE
nitrofurantoin (monohydrate/macrocrystals) drug variants not containing SODIUM LAURYL SULFATE
Excipient focus: STARCH, CORN
nitrofurantoin (monohydrate/macrocrystals) drug variants containing STARCH, CORN
nitrofurantoin (monohydrate/macrocrystals) drug variants not containing STARCH, CORN
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SUCROSE
nitrofurantoin (monohydrate/macrocrystals) drug variants containing SUCROSE
nitrofurantoin (monohydrate/macrocrystals) drug variants not containing SUCROSE
Excipient focus: TALC
nitrofurantoin (monohydrate/macrocrystals) drug variants containing TALC
nitrofurantoin (monohydrate/macrocrystals) drug variants not containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
nitrofurantoin (monohydrate/macrocrystals) drug variants containing TITANIUM DIOXIDE
nitrofurantoin (monohydrate/macrocrystals) drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - HIPAA-ready chat for life sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - HIPAA-ready chat for life sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
